HomeAKBA • NASDAQ
add
Akebia Therapeutics Inc
Previous close
$2.38
Day range
$2.28 - $2.41
Year range
$0.80 - $2.47
Market cap
504.00M USD
Avg Volume
2.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 37.43M | -10.98% |
Operating expense | 44.01M | -2.30% |
Net income | -20.04M | -38.30% |
Net profit margin | -53.54 | -55.37% |
Earnings per share | -0.10 | -31.49% |
EBITDA | -3.13M | 9.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.02M | -26.89% |
Total assets | 207.14M | -11.85% |
Total liabilities | 257.54M | -6.15% |
Total equity | -50.40M | — |
Shares outstanding | 218.18M | — |
Price to book | -9.92 | — |
Return on assets | -14.63% | — |
Return on capital | -50.56% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -20.04M | -38.30% |
Cash from operations | -6.70M | 6.59% |
Cash from investing | -2.00K | — |
Cash from financing | 1.22M | 2,346.00% |
Net change in cash | -5.47M | 23.09% |
Free cash flow | -36.39M | -583.62% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
167
